论文部分内容阅读
目的比较血脂康与辛伐他汀治疗老年高脂血症的临床疗效。方法将64例患者随机分为治疗组和对照组,治疗组服用血脂康胶囊0.6g,2次/d。对照组服用辛伐他汀片20mg,每晚1次,两组疗程均为2个月。结果两组TC、TG、HDL-C、LDL-C两组自身治疗前后比较差异有统计学意义(P<0.01),两组治疗后比较(P>0.05)差异无统计学意义,临床总有效率比较(P>0.05)无统计学差异。结论血脂康与他汀类比较除具有较好的调脂作用外,还有价格低廉,不良反应小,安全性高,耐受性好的优点。对合并心脑血管疾病的原发高脂血症老年患者,血脂康是心脏血管疾病二级预防的理想降脂药。
Objective To compare the clinical effects of Xuezhikang and simvastatin in the treatment of senile hyperlipidemia. Methods 64 patients were randomly divided into treatment group and control group, the treatment group taking Xuezhikang capsule 0.6g, 2 times / d. The control group took simvastatin tablets 20mg, 1 night, two courses of treatment were 2 months. Results There was significant difference in TC, TG, HDL-C and LDL-C between the two groups before and after treatment (P <0.01). There was no significant difference between the two groups after treatment (P> 0.05) No significant difference in efficiency (P> 0.05). Conclusion Xuezhikang compared with statins in addition to having a good lipid-lowering effect, there are cheap, adverse reactions, high safety, good tolerance. For elderly patients with primary hyperlipidemia with cardiovascular and cerebrovascular diseases, Xuezhikang is an ideal lipid-lowering drug for secondary prevention of cardiovascular disease.